GlassScriptPhysician profile
Jessica Mason
NPI 1720632961
$1,045.71
in general payments reported to CMS, 2019-2025
17 companies · $420 in 2025
The $420 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $207 · 2022: $231 · 2023: $123 · 2024: $64.13 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $607.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $200.42 | 2022-2025 | |
| Emd Serono, INC. | $177.92 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $130.36 | 2022-2025 | Austedo, Austedo Xr, Austedo Xr |
| Novartis Pharmaceuticals Corporation | $123.68 | 2021 | |
| Amneal Pharmaceuticals LLC | $100.36 | 2021-2025 | Crexont |
| Ucb, INC. | $55.78 | 2022 | |
| Sanofi Pasteur INC. | $46.54 | 2022-2023 | |
| Pfizer INC. | $44.86 | 2024-2025 | |
| Scilex Pharmaceuticals INC. | $35.88 | 2022-2023 | Ztlido |
| Springworks Therapeutics, INC. | $25.69 | 2025 | Gomekli |
| Cranial Technologies, INC | $17.99 | 2022 | |
| Cycle Pharmaceuticals INC | $17.80 | 2025 | Ormalvi |
| Amgen INC. | $17.04 | 2025 | Uplizna |
| Astrazeneca Pharmaceuticals LP | $16.68 | 2025 | Wainua |
| Supernus Pharmaceuticals, INC. | $13.60 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $11.11 | 2022 | |
| Vivaquant INC, Dba Rhythm Express | $10.00 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Mason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.